SMMT vs. ARQT
Compare and contrast key facts about Summit Therapeutics Inc. (SMMT) and Arcutis Biotherapeutics, Inc. (ARQT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SMMT or ARQT.
Correlation
The correlation between SMMT and ARQT is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SMMT vs. ARQT - Performance Comparison
Key characteristics
SMMT:
1.34
ARQT:
0.95
SMMT:
4.89
ARQT:
1.78
SMMT:
1.66
ARQT:
1.20
SMMT:
5.31
ARQT:
0.87
SMMT:
14.21
ARQT:
5.30
SMMT:
31.77%
ARQT:
13.20%
SMMT:
299.45%
ARQT:
73.21%
SMMT:
-95.75%
ARQT:
-95.02%
SMMT:
-32.83%
ARQT:
-63.45%
Fundamentals
SMMT:
$17.42B
ARQT:
$1.82B
SMMT:
-$0.31
ARQT:
-$1.16
SMMT:
753.90
ARQT:
9.35
SMMT:
60.43
ARQT:
11.66
SMMT:
$0.00
ARQT:
$146.97M
SMMT:
-$40.00K
ARQT:
$131.10M
SMMT:
-$172.32M
ARQT:
-$82.41M
Returns By Period
In the year-to-date period, SMMT achieves a 38.13% return, which is significantly higher than ARQT's -2.98% return.
SMMT
38.13%
48.14%
16.82%
396.98%
48.72%
8.78%
ARQT
-2.98%
1.69%
29.95%
69.15%
-11.25%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SMMT vs. ARQT — Risk-Adjusted Performance Rank
SMMT
ARQT
SMMT vs. ARQT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Arcutis Biotherapeutics, Inc. (ARQT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SMMT vs. ARQT - Dividend Comparison
Neither SMMT nor ARQT has paid dividends to shareholders.
Drawdowns
SMMT vs. ARQT - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum ARQT drawdown of -95.02%. Use the drawdown chart below to compare losses from any high point for SMMT and ARQT. For additional features, visit the drawdowns tool.
Volatility
SMMT vs. ARQT - Volatility Comparison
Summit Therapeutics Inc. (SMMT) has a higher volatility of 60.73% compared to Arcutis Biotherapeutics, Inc. (ARQT) at 19.14%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than ARQT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SMMT vs. ARQT - Financials Comparison
This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Arcutis Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities